Cleveland Diagnostics

Developing blood-based prostate cancer diagnostic tests using protein analysis.

BiotechnologyMedical Diagnostics clevelanddx.com ↗

Company facts

Founded
2013
Employees
100
Headquarters
United States
Type
Private
Funding
Series E · $75M · 2024